Cargando…
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
INTRODUCTION: Triple-negative breast cancer (TNBC) is a subtype of highly malignant breast cancer with poor prognosis. TNBC is not amenable to endocrine therapy and often exhibit resistance to current chemotherapeutic agents, therefore, further understanding of the biological properties of these can...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303115/ https://www.ncbi.nlm.nih.gov/pubmed/25209360 http://dx.doi.org/10.1186/s13058-014-0434-6 |
_version_ | 1782353887131336704 |
---|---|
author | Pelicano, Hélène Zhang, Wan Liu, Jinyun Hammoudi, Naima Dai, Jiale Xu, Rui-Hua Pusztai, Lajos Huang, Peng |
author_facet | Pelicano, Hélène Zhang, Wan Liu, Jinyun Hammoudi, Naima Dai, Jiale Xu, Rui-Hua Pusztai, Lajos Huang, Peng |
author_sort | Pelicano, Hélène |
collection | PubMed |
description | INTRODUCTION: Triple-negative breast cancer (TNBC) is a subtype of highly malignant breast cancer with poor prognosis. TNBC is not amenable to endocrine therapy and often exhibit resistance to current chemotherapeutic agents, therefore, further understanding of the biological properties of these cancer cells and development of effective therapeutic approaches are urgently needed. METHODS: We first investigated the metabolic alterations in TNBC cells in comparison with other subtypes of breast cancer cells using molecular and metabolic analyses. We further demonstrated that targeting these alterations using specific inhibitors and siRNA approach could render TNBC cells more sensitive to cell death compared to other breast cancer subtypes. RESULTS: We found that TNBC cells compared to estrogen receptor (ER) positive cells possess special metabolic characteristics manifested by high glucose uptake, increased lactate production, and low mitochondrial respiration which is correlated with attenuation of mTOR pathway and decreased expression of p70S6K. Re-expression of p70S6K in TNBC cells reverses their glycolytic phenotype to an active oxidative phosphorylation (OXPHOS) state, while knockdown of p70S6K in ER positive cells leads to suppression of mitochondrial OXPHOS. Furthermore, lower OXPHOS activity in TNBC cells renders them highly dependent on glycolysis and the inhibition of glycolysis is highly effective in targeting TNBC cells despite their resistance to other anticancer agents. CONCLUSIONS: Our study shows that TNBC cells have profound metabolic alterations characterized by decreased mitochondrial respiration and increased glycolysis. Due to their impaired mitochondrial function, TNBC cells are highly sensitive to glycolytic inhibition, suggesting that such metabolic intervention may be an effective therapeutic strategy for this subtype of breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0434-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4303115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43031152015-01-23 Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential Pelicano, Hélène Zhang, Wan Liu, Jinyun Hammoudi, Naima Dai, Jiale Xu, Rui-Hua Pusztai, Lajos Huang, Peng Breast Cancer Res Research Article INTRODUCTION: Triple-negative breast cancer (TNBC) is a subtype of highly malignant breast cancer with poor prognosis. TNBC is not amenable to endocrine therapy and often exhibit resistance to current chemotherapeutic agents, therefore, further understanding of the biological properties of these cancer cells and development of effective therapeutic approaches are urgently needed. METHODS: We first investigated the metabolic alterations in TNBC cells in comparison with other subtypes of breast cancer cells using molecular and metabolic analyses. We further demonstrated that targeting these alterations using specific inhibitors and siRNA approach could render TNBC cells more sensitive to cell death compared to other breast cancer subtypes. RESULTS: We found that TNBC cells compared to estrogen receptor (ER) positive cells possess special metabolic characteristics manifested by high glucose uptake, increased lactate production, and low mitochondrial respiration which is correlated with attenuation of mTOR pathway and decreased expression of p70S6K. Re-expression of p70S6K in TNBC cells reverses their glycolytic phenotype to an active oxidative phosphorylation (OXPHOS) state, while knockdown of p70S6K in ER positive cells leads to suppression of mitochondrial OXPHOS. Furthermore, lower OXPHOS activity in TNBC cells renders them highly dependent on glycolysis and the inhibition of glycolysis is highly effective in targeting TNBC cells despite their resistance to other anticancer agents. CONCLUSIONS: Our study shows that TNBC cells have profound metabolic alterations characterized by decreased mitochondrial respiration and increased glycolysis. Due to their impaired mitochondrial function, TNBC cells are highly sensitive to glycolytic inhibition, suggesting that such metabolic intervention may be an effective therapeutic strategy for this subtype of breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0434-6) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-11 2014 /pmc/articles/PMC4303115/ /pubmed/25209360 http://dx.doi.org/10.1186/s13058-014-0434-6 Text en © Pelicano et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unre stricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Pelicano, Hélène Zhang, Wan Liu, Jinyun Hammoudi, Naima Dai, Jiale Xu, Rui-Hua Pusztai, Lajos Huang, Peng Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title | Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title_full | Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title_fullStr | Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title_full_unstemmed | Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title_short | Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential |
title_sort | mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mtor pathway and therapeutic potential |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303115/ https://www.ncbi.nlm.nih.gov/pubmed/25209360 http://dx.doi.org/10.1186/s13058-014-0434-6 |
work_keys_str_mv | AT pelicanohelene mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT zhangwan mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT liujinyun mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT hammoudinaima mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT daijiale mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT xuruihua mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT pusztailajos mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential AT huangpeng mitochondrialdysfunctioninsometriplenegativebreastcancercelllinesroleofmtorpathwayandtherapeuticpotential |